ROCKY-MOUNTAIN-SPOTTED-FEVER - A SEASONAL ALERT

被引:81
作者
WALKER, DH
机构
[1] Department of Pathology, University of Texas Medical Branch, Galveston, TX
关键词
D O I
10.1093/clinids/20.5.1111
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Rocky Mountain spotted fever occurs during seasonal tick activity. A history of exposure to tick-containing habitats within the 3- to 12-day incubation period is a key epidemiological factor. The signs of fever, headache, myalgia, nausea, vomiting, and anorexia at onset of infection are difficult to distinguish from those of self-limited viral infections, Rash usually appears later and, if present, progresses through a sequence of stages and distribution that are never pathognomonic. The effects of disseminated Rickettsia rickettsii infection of endothelial cells include increased vascular permeability, edema, hypovolemia, hypotension, prerenal azotemia, and, in life-threatening cases, pulmonary edema, shock, acute tubular necrosis, and meningoencephalitis, In severe cases, fluid management is a challenge. The clinical diagnosis, which is difficult, is rarely assisted by laboratory findings because antibodies are usually detected only in convalescence, and immunohistologic methods for detection of rickettsiae are unavailable in most clinics: Doxycycline is the treatment of choice except for pregnant or allergic patients, who are treated with chloramphenicol.
引用
收藏
页码:1111 / 1117
页数:7
相关论文
共 33 条
[1]  
Rocky Mountain Spotted Fever and Human Ehrlichiosis-United States, 1989 InfMmwr Morb Mortal Wkly Rep, 39, pp. 281-284, (1990)
[2]  
Rocky Mountain spotted fever-United States, 1990, MMWR Morb Mortal Wkly Rep, 40, pp. 451-459, (1991)
[3]  
Parker R.R., Rocky Mountain spotted fever: Results of fifteen years’ pro phylactic vaccination, Am J Trop Med, 21, pp. 369-383, (1941)
[4]  
Kaplowitz L.G., Fischer J.J., Sparling P.F., Rocky Mountain spotted fever: A clinical dilemma, Current Clinical Topics in Infectious Diseases, 2, pp. 89-108, (1981)
[5]  
Helmick C.G., Bernard K.W., D'angelo L.J., Rocky Mountain spotted fever: Clinical, laboratory, and epidemiological features of 262 cases, J Infect Dis, 150, pp. 480-488, (1984)
[6]  
Wilfert C.M., Maccormack J.N., Kleeman K., Et al., Epidemiology of Rocky Mountain spotted fever as determined by active surveillance, J Infect Dis, 150, pp. 469-479, (1984)
[7]  
Sexton D.J., Corey G.R., Rocky Mountain “spotless” and “almost spot less” fever: A wolf in sheep’s clothing, Clin Infect Dis, 15, pp. 439-448, (1992)
[8]  
Sexton D.J., Burgdorfer W., Clinical and epidemiologic features of Rocky Mountain spotted fever in Mississippi, 1933-1973, South Med J, 68, pp. 1529-1535, (1975)
[9]  
Hattwick M., O'brien R.J., Hanson B.F., Rocky Mountain spotted fever: Epidemiology of an increasing problem, Ann Intern Med, 84, pp. 732-739, (1976)
[10]  
Harrell G.T., Aikawa J.K., Pathogenesis of circulatory failure in Rocky Mountain spotted fever. Alterations in the blood volume and the thiocyanate space at various stages of the disease, Arch Intern Med, 83, pp. 331-347, (1949)